Pacira BioSciences, Inc. (PCRX)
Receivables turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 700,966 | 694,957 | 690,310 | 681,754 | 674,978 | 665,689 | 669,229 | 669,173 | 666,823 | 654,062 | 614,318 | 580,497 | 541,533 | 510,887 | 500,649 | 440,564 | 427,221 | 421,097 | 408,298 | 435,397 |
| Receivables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue (ttm) ÷ Receivables
= $700,966K ÷ $—K
= —
The receivables turnover ratio for Pacira BioSciences, Inc. is not provided for any of the periods ranging from March 31, 2020, to December 31, 2024. The lack of data on receivables turnover makes it challenging to assess the efficiency with which the company is collecting its accounts receivable. Receivables turnover ratio is a financial metric that indicates how many times a company converts its credit sales into cash over a specific period.
Since there is no information available for the receivables turnover ratio, further analysis is not possible at this time. It is important to consider additional financial ratios and information to gain a comprehensive understanding of Pacira BioSciences' financial performance and operational efficiency.
Peer comparison
Dec 31, 2024